Home » Topics » Disease categories and therapies » Urology

Urology
RSS

EDAP signs license agreement for microwave technology

Aug. 23, 1996

U.S. patent granted for (S)-oxybutynin

Aug. 16, 1996

Sepracor to develop (S)-doxazosin for BPH; U.S. patent granted

Aug. 16, 1996

Leiras claims oral delivery system for oxybutynin chloride

July 26, 1996

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

Positive results in trial of Cystistat in refractory interstitial cystitis patients

July 19, 1996

CGP-53153: Ciba-Geigy's steroidal 5alpha-reductase inhibitor as BPH therapy

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Cystistat covered under U.S. patent

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...